WHARTEXA 20B HUC-MSCs Exosome
Whartexa 20B HUC-MSCs Exosome is a professional-grade regenerative extracellular vesicle formulation developed by Nanoventra as part of the proprietary Whartexa Line.
Â
Derived from carefully processed Wharton’s Jelly Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs), this advanced exosome platform is engineered using precision purification, extracellular vesicle isolation, and cryopreservation technologies intended to support superior vesicle integrity, biological stability, and regenerative signaling performance.
Human-Derived Exosomes From:*
Wharton’s Jelly
Product image shown represents the finalized Whartexa formulation. Actual presentation may vary slightly depending on packaging updates, preservation configuration, and production optimization protocols.
Details
Quality
Related Products
Details
WHARTEXA 20B HUC-MSCs Exosome
Nanoventra develops advanced HUC-MSC-derived extracellular vesicle systems through controlled purification, cryopreservation, and vesicle isolation methodologies designed to maintain extracellular integrity, biological consistency, and regenerative signaling support.
​
Whartexa 20B is produced from carefully processed Wharton’s Jelly umbilical biological material and represents a professional high-concentration formulation within the proprietary Whartexa regenerative platform.
​
This formulation is optimized for advanced regenerative integration workflows requiring elevated extracellular vesicle concentration systems, laboratory-grade consistency, precision nano-vesicle handling, and biotechnology-oriented preparation standards.
Â
Human umbilical cord-derived extracellular vesicles continue to gain scientific attention for their regenerative communication relevance and their growing integration within regenerative biotechnology, dermatological science, scalp-focused applications, and advanced extracellular signaling research systems.
Key Features
-
Proprietary Whartexa regenerative exosome platform
-
Human Wharton’s Jelly HUC-MSC-derived extracellular vesicles
-
20 Billion particle concentration system
-
Professional high-concentration regenerative formulation
-
Advanced extracellular vesicle purification workflows
-
Controlled laboratory-grade isolation methodologies
-
Cryopreserved formulation maintained at −20°C
-
Enhanced vesicle stability and biological consistency
-
Professional regenerative and biotechnology-oriented integration
-
Advanced extracellular nano-vesicle handling systems
-
Research-focused exosome preparation protocols
Quality
Specifications
All Whartexa 20B HUC-MSCs Exosome formulations undergo controlled scientific quality verification through advanced extracellular vesicle processing systems, laboratory-oriented preparation workflows, and multi-stage purification methodologies.
​
Each preparation is processed under sterile laboratory-grade conditions with focused attention toward:
-
extracellular vesicle integrity
-
particle concentration consistency
-
biological stability
-
purification accuracy
-
advanced handling reproducibility
​
Nanoventra applies biotechnology-oriented quality systems designed to support formulation consistency across regenerative extracellular vesicle preparations and advanced exosome engineering platforms.
The Whartexa Line represents Nanoventra’s specialized regenerative biotechnology division focused on advanced extracellular vesicle refinement, controlled nano-vesicle preservation, and professional exosome formulation development.
Storage & Handling
-
Recommended storage temperature: −20°C
-
Maintain cryopreserved conditions during handling
-
Avoid repeated freeze-thaw exposure
-
Professional laboratory-oriented handling recommended